C.M. Bidwell & Associates »

Enanta Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2k 331 12.63
2021-12-31 $85k 1.1k 74.37

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Schwab Strategic Tr sht tm us tres (SCHO)
Vanguard Malvern Fds strm infproidx (VTIP)
Vanguard Total Stock Market ETF (VTI)
iShares Russell 2000 Index (IWM)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Vanguard Europe Pacific ETF (VEA)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Total Bond Market ETF (BND)
Schwab Strategic Tr 0 (SCHP)
Dimensional Etf Trust (DFAC)
Vanguard Intermediate-Term Bond ETF (BIV)

View all positions for C.M. Bidwell & Associates

Top funds holding Enanta Pharmaceuticals

Henderson Group
BlackRock
Farallon Capital Management
Krensavage Asset Management
Deep Track Capital
Vanguard Capital Management
Vanguard Portfolio Management
Millennium Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Hillsdale Investment Management
AQR Capital Management
Morgan Stanley

View all funds holding Enanta Pharmaceuticals